Abstract To prospectively evaluate the associations of dietary calcium and magnesium intake with cancer incidence and mortality, data of 24,323 participants of the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg), who were aged 35-64 years and cancer-free at recruitment (1994)(1995)(1996)(1997)(1998), were analyzed using multivariate Cox regression models. After an average follow-up time of 11 years, 2,050 incident cancers were diagnosed and 513 cancer deaths occurred. Dietary calcium intake was inversely but not statistically significantly associated with colorectal cancer risk (hazard ratio [HR] for per 100 mg increase in intake: 0.95; 95% confidence interval [CI]: 0.88, 1.02) and lung cancer risk (HR for per 100 mg increase in intake: 0.94; 95% CI: 0.87, 1.02). No statistically significant associations were observed between dietary calcium intake and site-specific or overall cancer incidence or mortality. Dietary magnesium intake was not statistically significantly associated with any of the investigated outcomes. This prospective cohort study provides no strong evidence to support that high dietary calcium and magnesium intake in the intake range observed in a German population may reduce cancer incidence or mortality.
Introduction
Besides its importance in maintaining bone health, calcium is also a key nutrient involved in processes of cell proliferation and carcinogenesis [1, 2] . Many epidemiological studies have evaluated the association between dietary calcium intake and risks of various cancer types. A growing body of evidence suggests a protective effect of high dietary calcium intake on colorectal cancer [3] [4] [5] [6] [7] [8] and breast cancer risk [9] [10] [11] [12] [13] [14] . Meanwhile, a number of studies have also suggested that high calcium intake might increase the risk of prostate cancer [15] [16] [17] [18] [19] [20] [21] .
Magnesium is another important mineral with various metabolic and physiological functions that may influence carcinogenesis [22] [23] [24] . Although animal studies have consistently suggested an inhibitory effect of dietary magnesium intake on colorectal cancer risk [25] [26] [27] [28] [29] , available epidemiological findings are few and far from being conclusive [30] [31] [32] [33] . Relationships between dietary magnesium intake and the risks of other common site-specific cancers have been scarcely reported in literatures.
So far, only one study has reported the associations between dietary calcium and magnesium intake and cancer mortality [34] . In that study, neither dietary calcium intake nor magnesium intake was associated with overall cancer mortality.
We hereby report the associations of dietary calcium and magnesium intake with cancer incidence and cancer mortality in a German prospective cohort.
Methods

Study population
Heidelberg is one of the two German areas that joined the European Prospective Investigation into Cancer and Nutrition (EPIC) study. In 1994-1998, 11,928 men (aged 40-64 years) and 13,612 women (aged 35-64 years) were recruited into the EPIC-Heidelberg cohort. The recruitment procedures have been described elsewhere [35] . The study protocol was approved by the Ethics Committee of the Heidelberg University Medical School. All participants provided informed consent. In the present study, we excluded participants whose total daily energy intake was in the top or bottom 0.5 sex-specific percentile (men:\887/[5,582 kcal/ day; women: \703/[4,381 kcal/day; n = 257) and participants with a diagnosis of cancer at recruitment stage (n = 953), leaving 24,323 participants for analysis.
Assessment of dietary calcium and magnesium intake and other exposures
Diet in the last 12 months before recruitment was assessed using a self-administered food frequency questionnaire (FFQ) that had been validated by 12 24-h diet recalls [36, 37] . Dietary intakes of nutrients were derived using the German Dietary Nutrient Database BSL, version II.3. For the entire EPIC-Germany cohort, the main dietary sources of calcium were milk/milk products (39.9% for men and 38.7% for women) and non-alcoholic beverages (28.2% for men and 34.4% for women); the main dietary sources of magnesium were non-alcoholic beverages (25.1% for men and 33.7% for women) and cereals (22.6% for men and 20.6% for women) [38] . At food group level, the Spearman correlation coefficient between the mean of 12 24-h diet recalls and FFQ was 0.58 for milk/milk products and cheese, 0.70 for non-alcoholic beverages, and 0.55 for cereals [36] . Regular use of dietary supplements in the last 4 weeks before recruitment was assessed. However, dosage data were not collected. Baseline demographic, lifestyle, and other health-related data were collected in a face-toface interview and by questionnaires.
Ascertainment of disease outcomes
Incident diseases and deaths that occurred during follow-up were reported by study participants or their next of kin in regular follow-up questionnaire surveys. Reported incident diseases were verified by reviewing medical records from hospitals. For deceased participants, the underlying cause of death was obtained from the official death certificate.
In the present study, disease outcomes of interest, along with the corresponding codes in the International Classification of Disease (10th Revision, ICD-10), included: incident colorectal cancer (C18-C20), incident lung cancer (C34), incident prostate cancer (C61), incident breast cancer (C50), and overall cancer incidence and mortality (B21 and C00-C97).
Statistical analyses
The residual method [39] was used to adjust dietary nutrient intakes for total energy intake. We categorized energy-adjusted dietary calcium and magnesium intake into quartiles using sex-specific cut-off points. To compare age-adjusted baseline characteristics across quartiles, we performed analysis of covariance and logistic regression [40] . Multivariate Cox regression models were fitted to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for both quartiles and per 100 mg increase in dietary calcium and magnesium intake. For the former, likelihood ratio tests were performed to test the statistical significance of linear trend, with medians of quartiles modeled as a continuous variable. For the latter, energy-adjusted calcium and magnesium intake were divided by 100 so that one unit represented an actual intake of 100 mg. Multivariate models adjusted for the following covariates: sex, age at recruitment (years), educational level (none/primary, technical/secondary, and university), physical activity (inactive, moderately inactive, moderately active, and active [41] ), body mass index (BMI, kg/m 2 ), waist-to-hip ratio, smoking categories (never smoker; former smoker, quit C10 years, quit \10 years; and current smoker, B10, 11-20, [ 20 cigarettes/day), lifetime alcohol intake (g/day), dietary fiber intake (g/day), meat/meat product intake (g/day), and total energy intake (kcal/day). All these covariates, with exception of sex and calcium/vitamin D supplementation, altered the exposure-disease effect for 5% or greater. For the analysis of dietary calcium intake, dietary vitamin D and K 2 intake (lg/day) and regular use of calcium/vitamin D supplements (yes/no) were additionally adjusted for. The reason for adjusting for dietary vitamin K 2 intake is that vitamin K 2 intake, which closely correlates with dietary calcium intake (r = 0.63), was significantly inversely associated with lung and prostate cancer incidence and overall cancer mortality in our cohort [42] .
For overall cancer incidence and mortality, we further performed a sex-specific analysis and 2-year lag analysis by excluding cancer cases or deaths that occurred in the first 2 years of follow-up. Two-sided p \ 0.05 was considered statistically significant. SAS software (version 9.2; SAS Institute, Cary, NC) was used to perform all statistical analyses.
Results
Age-adjusted baseline characteristics of participants are shown in Table 1 . Participants with higher dietary calcium and magnesium intake were more likely to have a university degree, to be physically active, and to regularly take calcium/vitamin D supplements. Participants with higher dietary calcium intake also had a shorter smoking duration and a lower lifetime alcohol intake. Higher dietary calcium and magnesium intake were associated with certain favorable dietary factors, such as higher dietary intakes of vitamin D and fiber, but a lower intake of meat/meat products.
During an average follow-up time of 11 years, 2,050 incident cancer cases were diagnosed and 513 cancer deaths occurred. Dietary calcium intake in quartiles was not statistically significantly associated with overall or common site-specific (colorectum, lung, prostate, and breast) cancer incidence and overall cancer mortality ( Table 2) . We also ran models without adjusting for vitamin K 2 intake, resulting in a statistically significantly inverse association of dietary calcium intake with lung cancer risk (HR for highest vs. lowest quartile: 0.61; 95% CI: 0.38, 0.98; p trend = 0.02), a non-significantly inverse association with prostate cancer risk (HR for highest vs. lowest quartile: 0.77; 95% CI: 0.56, 1.05; p trend = 0.07), and a non-significantly inverse association with overall cancer mortality (HR for highest vs. lowest quartile: 0.79; 95% CI: 0.61, 1.02; p trend = 0.07). When treated as a continuous variable, per 100 mg increase in dietary calcium intake was inversely yet not statistically significantly associated with colorectal cancer risk (HR: 0.95; 95% CI: 0.88, 1.02) and lung cancer risk (HR: 0.94; 95% CI: 0.87, 1.02).
As shown in Table 3 , dietary magnesium intake, either in quartiles or as a continuous variable, was not statistically significantly associated with overall cancer incidence and mortality. For site-specific cancer incidence, per 100 mg increase in dietary magnesium intake was inversely but not statistically significantly associated with lung cancer risk (HR: 0.75; 95% CI: 0.51, 1.11).
The sex-specific analysis and exclusion of cases diagnosed within the first 2 years after recruitment did not produce substantially different results (data not shown). 
Discussion
After an average follow-up time of 11 years of the EPICHeidelberg cohort, we observed statistically non-significantly inverse associations of dietary calcium intake with colorectal and lung cancer risk. There were no statistically significant associations between dietary magnesium intake and cancer incidence and mortality.
Dietary calcium intake
In the present study, dietary calcium intake was not associated with overall cancer incidence, in contrast to a previous study showing a significantly inverse association in women but not in men [43] . In our cohort, the null association between dietary calcium intake and overall cancer incidence was not modified by sex. Two meta-analyses of observational and interventional studies consistently suggest that high dietary calcium intake may reduce colorectal cancer risk [3, 44] . A possible mechanism for this protective effect is that free calcium in colon can bind bile acids and fatty acids and consequently prohibit the proliferation and differentiation of colorectal epithelial cell [45] [46] [47] [48] [49] .
In the present study, we observed no significantly inverse association between the energy-adjusted dietary calcium intake and colorectal cancer risk. However, the absolute dietary calcium intake was significantly inversely associated with colorectal cancer risk according to the standard model that controlled for total energy intake as a confounder (HR for highest vs. lowest quartile: 0.46; 95% CI: 0.26, 0.79; p trend = 0.01).
The relationship between dietary calcium intake and lung cancer risk has been rarely reported. Our finding of the non-significantly inverse association is not in agreement with the results of two previous observational studies, which showed either a significant positive association or a null association [43, 50] . However, in the model that ignored dietary vitamin K 2 intake, the association became statistically significant, suggesting a confounding effect of dietary vitamin K 2 . We observed no statistically significant association between dietary calcium intake and prostate cancer risk, consistent with the result of a meta-analysis of 45 observational studies [51] , but not in line with the significant positive association reported in another meta-analysis of 10 prospective cohort studies, in which the median dietary calcium intake of the highest category ranged from 1,329 to 2,250 mg/day [21] . In the EPIC-Heidelberg cohort, the median dietary calcium intake of the highest quartile was 1,132 mg/day. We may assume that only a very high dietary calcium intake can increase prostate cancer risk.
However, a cohort study of Chinese men has suggested that dietary calcium intake may increase prostate cancer risk even at a substantially low intake [52] , implying that the real dose-response relationship could be complicated. On the other hand, the primary source of calcium in western diets is milk and milk products. Besides calcium, some other dairy components, such as saturated fat, dairy protein, and hormones, are also risk factors for prostate cancer [15, 53, 54] and therefore may confound the association between dietary calcium intake and prostate cancer risk. In the present study, however, adjustment for milk/milk product intake did not substantially change the association between dietary calcium intake and prostate cancer risk. Meanwhile, milk/milk product intake itself was not statistically significantly associated with prostate cancer risk either. Some studies have suggested that high dietary calcium intake might have a more pronounced adverse effect Adjusted for sex, age at recruitment, educational level, physical activity, BMI, waist-to-hip ratio, smoking category, lifetime alcohol intake, meat/meat product intake, dietary intake of fiber, and total energy intake. For colorectal, lung, and prostate cancer incidence and overall cancer mortality, dietary calcium and vitamin K 2 intake were additionally adjusted for
Participants with a diagnosis of cancer at recruitment and participants whose total daily energy intake was in the top or bottom 0. on advanced/fatal prostate cancer risk [20, 55, 56] . However, the present study observed no such a result (data not shown). Again, the present study reveals a confounding effect of dietary vitamin K 2 on the association between dietary calcium intake and prostate cancer risk, as suggested by the strengthened inverse association in the vitamin K 2 -unadjusted model. We observed no significantly inverse association between dietary calcium intake and breast cancer risk as reported in previous studies [9] [10] [11] [12] [13] [14] . Some of these studies showed that the inverse association was particularly strong for premenopausal women [10, 11, 13, 14] . In the present study, however, menopausal status did not modify the null association (data not shown).
In the present study, the vitamin K 2 -unadjusted model produced an inverse association between dietary calcium intake and overall cancer mortality, not supporting the null association reported in one prospective study of Swedish men [34] . In our cohort, dietary vitamin K 2 intake was significantly inversely associated with overall cancer morality (HR for highest vs. lowest quartile: 0.72; 95% CI: 0.53, 0.85; p trend = 0.03) [42] . The substantially attenuated inverse association due to the adjustment for dietary vitamin K 2 intake suggests that dietary calcium intake may have no independent effect on overall cancer mortality. It is also notable that the mean energy-adjusted dietary calcium intake in the Swedish male cohort was much higher than that in our cohort (1,400 vs. 784 mg/day for the entire cohort and 795 mg/day for the sub-cohort of men). In such a population that is less likely to have suboptimal calcium supply, an independent effect of dietary calcium intake, assuming it really exists, may be more difficult to detect.
Dietary magnesium intake
To the best of our knowledge, the association between dietary magnesium intake and overall cancer incidence has never been reported before, and thus, the null association that we observed here needs to be confirmed or refuted by others. For site-specific cancer incidence, our result supports the finding of a Dutch cohort study that dietary magnesium intake was not associated with colorectal cancer risk [33] . Three other prospective cohort studies of women reported either a significantly inverse association or a null association [30] [31] [32] . The average energy-adjusted dietary magnesium intakes in these cohorts were 289, 232, and 329 mg/day, respectively, comparable to that of our female sub-cohort (288 mg/day). However, the small number of incident colorectal cancer cases in our cohort does not permit a meaningful separate analysis for women.
So far, only very few epidemiological studies have evaluated the association between dietary magnesium intake and lung, prostate, and breast cancer risk. In one case-control study, dietary magnesium intake was significantly inversely associated with lung cancer risk [57] . In the present study, the association was inverse but not statistically significant. Another case-control study showed a moderate inverse association between magnesium level in drinking water and prostate cancer mortality [58] . However, the relationship for magnesium intake from food has never been reported. As the result of the present study suggests, dietary magnesium intake might have no association with prostate cancer risk, whether for overall prostate cancer or for advanced and non-advanced types separately. The null association of dietary magnesium intake with overall cancer mortality in the present study is in agreement with the result of the Swedish male cohort [34] . Based on these limited data, it seems that dietary magnesium intake might have no effect on cancer incidence and mortality. However, a solid conclusion could not be drawn until more evidence becomes available.
Several limitations of the present study should be noted. Firstly, a FFQ, even though it has been validated before application, is a relatively rough instrument to quantify nutrient intakes and thus results are affected by measurement error. Secondly, as shown in the present study, participants with higher dietary calcium intake were more likely to take calcium/vitamin D supplements. However, calcium intake from supplements was not quantified. Lastly, some important cancer risk factors, such as family history and cancer screening, were not adjusted for in the present study, and therefore, residual confounding may exist. However, we additionally adjusted for dietary vitamin K 2 intake, an important confounder that had not been controlled for in any of the previous studies.
In summary, this German prospective cohort study provides no strong evidence to support that high dietary calcium and magnesium intake in the intake range observed in a German population may reduce the risk of cancer incidence, in total or for common site-specific types, and overall cancer mortality.
